Tema Healthcare AI ETF is an actively managed exchange-traded fund that focuses on the intersection of artificial intelligence and healthcare. It targets global life science, tech, and medical companies driving AI-integrated drug discovery, robotic surgery, and healthcare operational efficiencies.

10x Genomics, Inc.

Twist Bioscience Corporation

Cytokinetics, Incorporated

Illumina, Inc.

Revolution Medicines, Inc.

Natera, Inc.

Vertex Pharmaceuticals Incorporated

Intuitive Surgical, Inc.

Cogent Biosciences, Inc.

Stoke Therapeutics, Inc.

Tema Healthcare AI ETF

Cue Health Inc. is a healthcare technology firm dedicated to engineering and deploying advanced diagnostic platforms. These platforms facilitate various diagnostic tests, serving a broad spectrum of clients including individuals, enterprises, healthcare providers, payors, and public health agencies. Central to their offerings is the Cue Integrated Care platform, a comprehensive solution combining both physical hardware and sophisticated software. This platform encompasses the Cue Health Monitoring System, which features the portable, reusable Cue Reader, along with single-use Cue Cartridges and Cue Wands for sample collection. Digitally, it is supported by the Cue Data and Innovation Layer, offering robust cloud-based data and analytics capabilities, and the Cue Virtual Care Delivery Apps, including the consumer-focused Cue Health App and the business-oriented Cue Enterprise Dashboard. Additionally, the Cue Ecosystem Integrations and Apps provide seamless connectivity for third-party applications and sensors. The company also supplies specialized COVID-19 testing kits designed for use with its proprietary monitoring system. Established in 2010 and headquartered in San Diego, California, the organization originally operated as Cue Inc. before rebranding to Cue Health Inc. in December 2017.

HLTH Holdings & Sector Breakdown